Close

Dr Angel Wong

BSc PhD

Research Fellow

Room
256

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
020 7927 2622

I obtained my undergraduate degree in Public Health at the Chinese University of Hong Kong. Then I completed my PhD in Pharmacoepidemiology at the University of Hong Kong, focusing on the use of different observational study designs and methodologies to investigate the adverse cardiovascular effects of macrolide antibiotics. I have been awarded a British Heart Foundation fellowship to study drug-drug interactions using routine care data.

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Teaching

I am currently the co-director of the LSHTM Distance Learning Postgraduate Professional Development Course in Pharmacoepidemiology and Pharmacovigilance. I am the tutor on the Basic Epidemiology module.

Research

My main research area is pharmacoepidemiology, focusing on the use of different study designs and methodologies, including within-person study designs and propensity score method to address bias and confounding.

I currently hold a British Heart Foundation Immediate Postdoctoral Basic Science Research Fellowship for research studies investigating drug-drug interactions in the UK and Hong Kong. I am also involved in studies examining drug effects on renal outcomes, and the role of stress in skin and renal diseases using clinical data from the UK and Denmark. 

Research Area
Clinical databases
Electronic health records
Methodology
Discipline
Pharmacoepidemiology
Epidemiology
Disease and Health Conditions
Cardiovascular disease
Kidney disease
Skin disease
Country
Denmark
United Kingdom
Hong Kong SAR, China

Selected Publications

Partner Bereavement and Detection of Dementia: A UK-Based Cohort Study Using Routine Health Data.
Forbes HJ; Wong AYS; Morton C; Bhaskaran K; Smeeth L; Richards M; Schmidt SAJ; Langan SM; Warren-Gash C
2019
Journal of Alzheimer's Disease
Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture.
Sing CW; Wong AY; Kiel DP; Cheung EY; Lam JK; Cheung TT; Chan EW; Kung AW; Wong IC; Cheung CL
2018
Journal of bone and mineral research
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.
Wong AYS; Chan EW; Anand S; Worsley AJ; Wong ICK
2017
Drug safety
Association between oral fluoroquinolones and seizures: A self-controlled case series study.
Chui CS; Chan EW; Wong AY; Root A; Douglas IJ; Wong IC
2016
Neurology
Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin.
Wong AYS; Wong ICK; Chui CSL; Lee EHM; Chang WC; Chen EYH; Leung WK; Chan EW
2016
JAMA internal medicine
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs.
Root AA; Wong AY; Ghebremichael-Weldeselassie Y; Smeeth L; Bhaskaran K; Evans SJ; Brauer R; Wong IC; Navaratnam V; Douglas I
2016
British journal of clinical pharmacology
Cardiovascular outcomes associated with use of clarithromycin: population based study.
Wong AY; Root A; Douglas IJ; Chui CS; Chan EW; Ghebremichael-Weldeselassie Y; Siu CW; Smeeth L; Wong IC
2016
BMJ (Clinical research ed)
Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs.
Chan EW; He Y; Chui CSL; Wong AYS; Lau WCY; Wong ICK
2013
Obesity reviews : an official journal of the International Association for the Study of Obesity
Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.
He Y; Wong AYS; Chan EW; Lau WCY; Man KKC; Chui CSL; Worsley AJ; Wong ICK
2013
BMC musculoskeletal disorders
See more Publications